ENOV
Price
$31.54
Change
+$0.48 (+1.55%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
1.78B
21 days until earnings call
Intraday Buy/Sell Signals
MASI
Price
$147.45
Change
-$0.56 (-0.38%)
Updated
Oct 14 closing price
Capitalization
8.01B
27 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ENOV vs MASI

Header iconENOV vs MASI Comparison
Open Charts ENOV vs MASIBanner chart's image
Enovis
Price$31.54
Change+$0.48 (+1.55%)
Volume$431
Capitalization1.78B
Masimo
Price$147.45
Change-$0.56 (-0.38%)
Volume$500.28K
Capitalization8.01B
ENOV vs MASI Comparison Chart in %
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENOV vs. MASI commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and MASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (ENOV: $31.06 vs. MASI: $147.45)
Brand notoriety: ENOV and MASI are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 101% vs. MASI: 75%
Market capitalization -- ENOV: $1.78B vs. MASI: $8.01B
ENOV [@Medical/Nursing Services] is valued at $1.78B. MASI’s [@Medical/Nursing Services] market capitalization is $8.01B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.95B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 5 TA indicator(s) are bullish while MASI’s TA Score has 5 bullish TA indicator(s).

  • ENOV’s TA Score: 5 bullish, 3 bearish.
  • MASI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ENOV is a better buy in the short-term than MASI.

Price Growth

ENOV (@Medical/Nursing Services) experienced а +2.41% price change this week, while MASI (@Medical/Nursing Services) price change was -1.86% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.45%. For the same industry, the average monthly price growth was +4.47%, and the average quarterly price growth was +22.03%.

Reported Earning Dates

ENOV is expected to report earnings on Nov 06, 2025.

MASI is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.45% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($8.01B) has a higher market cap than ENOV($1.78B). MASI YTD gains are higher at: -10.799 vs. ENOV (-29.216). MASI has higher annual earnings (EBITDA): -115.8M vs. ENOV (-472.1M). MASI has more cash in the bank: 150M vs. ENOV (44.1M). MASI has less debt than ENOV: MASI (642M) vs ENOV (1.47B). ENOV (2.19B) and MASI (2.15B) have equivalent revenues.
ENOVMASIENOV / MASI
Capitalization1.78B8.01B22%
EBITDA-472.1M-115.8M408%
Gain YTD-29.216-10.799271%
P/E RatioN/A116.80-
Revenue2.19B2.15B102%
Total Cash44.1M150M29%
Total Debt1.47B642M228%
FUNDAMENTALS RATINGS
ENOV vs MASI: Fundamental Ratings
ENOV
MASI
OUTLOOK RATING
1..100
914
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
7858
P/E GROWTH RATING
1..100
9915
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENOV's Valuation (80) in the Industrial Machinery industry is in the same range as MASI (91) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to MASI’s over the last 12 months.

ENOV's Profit vs Risk Rating (100) in the Industrial Machinery industry is in the same range as MASI (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to MASI’s over the last 12 months.

ENOV's SMR Rating (97) in the Industrial Machinery industry is in the same range as MASI (97) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to MASI’s over the last 12 months.

MASI's Price Growth Rating (58) in the Medical Specialties industry is in the same range as ENOV (78) in the Industrial Machinery industry. This means that MASI’s stock grew similarly to ENOV’s over the last 12 months.

MASI's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for ENOV (99) in the Industrial Machinery industry. This means that MASI’s stock grew significantly faster than ENOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVMASI
RSI
ODDS (%)
N/A
Bullish Trend 10 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 8 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 8 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 8 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 8 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 8 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 8 days ago
66%
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
Bearish Trend 29 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 8 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 8 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BREUX40.950.74
+1.84%
Baron Real Estate R6
BCVCX32.73N/A
N/A
Sterling Capital Behav Lg Cp Val Eq C
TPLIX15.05N/A
N/A
Timothy Plan Large/Mid Cap Growth I
WVAIX53.41N/A
N/A
Weitz Large Cap Equity-Institutional Cl
JAMCX35.83N/A
N/A
JPMorgan Mid Cap Value A

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+4.47%
CNMD - ENOV
61%
Loosely correlated
+2.60%
IART - ENOV
60%
Loosely correlated
+5.73%
FELE - ENOV
56%
Loosely correlated
+1.26%
ITGR - ENOV
56%
Loosely correlated
+1.83%
DOV - ENOV
55%
Loosely correlated
+0.86%
More

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with ITGR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
-0.38%
ITGR - MASI
52%
Loosely correlated
+1.83%
SYK - MASI
50%
Loosely correlated
+1.39%
BSX - MASI
48%
Loosely correlated
+1.36%
ISRG - MASI
48%
Loosely correlated
+0.15%
ENOV - MASI
47%
Loosely correlated
+4.47%
More